Bildkälla: Stockfoto

Cantargia: Redeye provides a comment on the latest data from CANOPY-1 - Redeye

Novartis presented new data from its CANOPY-1 trial at the AARC annual meeting yesterday.

Novartis presented new data from its CANOPY-1 trial at the AARC annual meeting yesterday.
Börsvärldens nyhetsbrev
ANNONSER